West Orange, N.J.-based RWJBarnabas Health named Jonathan Kyriacou as president and CEO of Jersey City (N.J.) Medical Center, effective Jan. 26.
Mr. Kyriacou most recently served as COO of The Mount Sinai Hospital in New York City, a 1,134-bed academic medical center, according to a Jan. 6 RWJBarnabas news release shared with Becker’s. He managed a $4 billion operating budget and led more than 15,000 employees during his tenure.
At Mount Sinai, he oversaw a $750 million master capital plan, expanded clinical services through a five-year strategic plan and helped establish the Institute for Critical Care Medicine. He also directed the hospital’s COVID-19 response, including expanding capacity to 1,600 beds and launching large-scale testing and vaccination centers.
As CEO of Jersey City Medical Center, a 352-bed teaching hospital, Mr. Kyriacou will oversee day-to-day operations and lead key strategic initiatives to advance RWJBarnabas Health’s mission.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
